Has Saraschandra Vallabhajosyula, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,330 in general payments to Saraschandra Vallabhajosyula, MD across 32 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Saraschandra Vallabhajosyula, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Saraschandra Vallabhajosyula, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Saraschandra Vallabhajosyula, MD

Interventional Cardiology · Providence, RINPI 1740535632

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Teleflex LLC at 33.6% of the total. 2025 is the largest year on record at $966, 6.9 times the $140 reported in 2020. That places this record below the midpoint for interventional cardiology clinicians in RI, where the typical reported total is $3,343.

$2,330in general payments, 2019–2025

Across 32 payments — averaging $72.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Teleflex LLC$784
Getinge USA Sales, LLC$392
Medtronic$275
Abiomed$208
Boston Scientific$178
Inari Medical, Inc.$167
plus $327 from 4 others

What the payments were for

Food & beverage$2,19094%
Education$1406%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Teleflex LLC	6	$784
Getinge USA Sales, LLC	5	$392
Medtronic(2 entities)	5	$275
Abiomed	2	$208
Boston Scientific	2	$178
Inari Medical, Inc.	6	$167
Livanova USA, Inc.	1	$133
Datascope Corp.	1	$110
Angiodynamics, Inc.	2	$58
AstraZeneca	2	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MANTA$383
CARDIOSAVE RESCUE$257
CARDIOHELP$223
Resolute$140
LifeSPARC$133
OPTICROSS$126
Impella$119
TELEMARK MICROCATHETER$102

How this compares

$2,330 in reported general payments places this provider in the 35th percentile of 23 interventional cardiology providers in Rhode Island.

See all interventional cardiology providers in Rhode Island →

Medicare billing

Part B allowed, 2024

$108,686

Medicare patients

200

Services billed

765

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EntrestoSacubitril/Valsartan	65	$73,416
EliquisApixaban	57	$51,648
JardianceEmpagliflozin	17	$12,541
Rosuvastatin Calcium	182	$3,630
Atorvastatin Calcium	194	$2,505
Metoprolol Succinate	162	$2,352
Isosorbide Mononitrate ErIsosorbide Mononitrate	102	$1,588
Ezetimibe	44	$1,396
Metoprolol Tartrate	114	$972
Spironolactone	83	$898
Carvedilol	76	$593
Losartan Potassium	63	$568
Lisinopril	26	$369
Furosemide	54	$356
Hydralazine Hcl	18	$344

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Providence

Peter SoukasProvidence$798K
Jinnette AbbottProvidence$156K
Marwan SaadProvidence$57K
Hafiz ImranProvidence$18K
Paul GordonProvidence$13K
Omar HyderProvidence$9K
Anum AsifProvidence$6K
Ahmed ElkaryoniProvidence$3K
Barry SharafProvidence$3K
Mitchel SklarProvidence$2K

See the full list for Rhode Island →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →